ClinicalTrials.Veeva

Find clinical trials for Heart Disease in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Coronary Artery Disease
Cardiovascular Diseases
Myocardial Ischemia
Heart Failure
Coronary Disease
Hypertension

Heart Disease trials near Houston, TX, USA:

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...

Enrolling
Heart Valve Diseases
Aortic Valve Disease
Device: Navitor Transcatheter Aortic Valve Implantation (TAVI) System
Device: Any Commercially Available Transcatheter Aortic Valve (CAV) System
Abbott
Abbott

Houston, Texas, United States and 17 other locations

other places in the body (metastatic). Telotristat ethyl and somatostatin analog therapy may help to control carcinoid syndrome and carcinoid heart...

Enrolling
Metastatic Neuroendocrine Neoplasm
Locally Advanced Neuroendocrine Neoplasm
Other: Questionnaire Administration
Drug: Telotristat Ethyl

Phase 3

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

Safety and performance evaluation of the preCARDIA System for patients with ADHF.

Enrolling
Acute Heart Failure
Acute Decompensated Heart Failure
Device: preCARDIA system
Abiomed
Abiomed

Houston, Texas, United States and 16 other locations

PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...

Active, not recruiting
Pediatric Heart Failure
Device: Surgical placement of the Jarvik 2015 VAD
Procedure: Surgical Placement of Jarvik 2015 VAD

Early Phase 1

Carelon Research

Houston, Texas, United States and 6 other locations

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...

Enrolling
Single Ventricle Heart Disease
Drug: Udenafil
Drug: Placebo

Phase 3

Mezzion Pharmaceuticals

Houston, Texas, United States and 21 other locations

Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect

Enrolling
Heart Defects, Congenital
Cardiovascular Diseases
Device: reSept ASD Occluder
atHeart Medical

Houston, Texas, United States and 27 other locations

To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart...

Active, not recruiting
Pulmonary Disease
Congenital Heart Disease
Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 THV
Edwards Lifesciences
Edwards Lifesciences

Houston, Texas, United States and 13 other locations

This is a Phase 2, multicenter, double-blind, sponsor unblinded, placebo-controlled, single-dose clinical study of CRD-4730 to evaluate the safety, t...

Enrolling
Heart Defects, Congenital
Heart Diseases
Drug: CRD-4730
Drug: Placebo

Phase 2

Cardurion Pharmaceuticals

Houston, Texas, United States and 10 other locations

native aortic regurgitation who are judged by a multi-disciplinary heart team to be eligible for the device and to be at high risk for open ...

Enrolling
Aortic Valve Disease
Aortic Regurgitation
Device: J-Valve TF System
JC Medical

Houston, Texas, United States and 8 other locations

The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system. The Pivotal/CAS phases of the study have tr...

Active, not recruiting
Congenital Heart Disease
Tetrology of Fallot
Device: Harmony TPV System
Medtronic
Medtronic

Houston, Texas, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems